|Articles|October 6, 2009
Humedica Launches Next-Generation Clinical Informatics Platform
Advertisement
BOSTON, MA
In response to a growing demand for essential clinical information, Humedica has developed a clinical informatics solution that addresses the specific needs of inpatient and outpatient health care providers, pharmaceutical and biotechnology firms, medical device manufacturers, government agencies and financial services firms. Currently being implemented in select hospitals and medical groups throughout the country, Humedica’s software-as-a-service (SaaS) solution connects patient information across varied medical settings and time periods to generate a comprehensive view of patient care.
“...Humedica offers a complete picture of health care delivery, bringing together clinical, operational, and financial data to help answer both pressing real-time questions and to address topics at the center of health care reform that require comparative analyses and benchmarking information,” said Michael Weintraub, President and CEO of Humedica.
Humedica has developed an analytics platform that effectively overcomes barriers of accessing relevant clinical information, transforming real-time and retrospective data into actionable knowledge. Humedica applies sophisticated techniques to mine, standardize, and aggregate health care data from disparate IT systems, all within a HIPAA-compliant, and highly secure environment.
Humedica’s SaaS-based clinical informatics portfolio offers analytics, reporting, and benchmarking.
The company also disclosed it received $30 million in capital from Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners, and Leerink Swann.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
Q&A: Strategies for Successful Global Clinical Trial Delivery
3
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
4
Latest NIMBLE Study Results Highlight Progress in gMG Research
5